INIS
reviews
100%
myeloid leukemia
100%
patients
40%
philadelphia chromosome
40%
stem cells
20%
neoplasms
20%
chromosomes
20%
karyotype
20%
translocation
20%
blasts
20%
Pharmacology, Toxicology and Pharmaceutical Science
Case Report
100%
Chronic Myeloid Leukemia
100%
Neoplasm
20%
Prognosis
20%
Imatinib
20%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Cytogenetics
40%
Philadelphia Chromosome
40%
Stem Cell
20%
Chromosome
20%
Imatinib
20%
Karyotype
20%
Nursing and Health Professions
Philadelphia 1 Chromosome
40%
Imatinib
20%
Patient with Leukemia
20%
Blast Cell Crisis
20%
Medicine and Dentistry
Philadelphia 1 Chromosome
40%
Imatinib
20%
Blast Cell Crisis
20%